Tian, Ruilin https://orcid.org/0000-0001-7680-6682
Abarientos, Anthony
Hong, Jason
Hashemi, Sayed Hadi
Yan, Rui https://orcid.org/0000-0003-3391-133X
Dräger, Nina
Leng, Kun https://orcid.org/0000-0001-9931-1375
Nalls, Mike A.
Singleton, Andrew B.
Xu, Ke https://orcid.org/0000-0002-2788-194X
Faghri, Faraz https://orcid.org/0000-0001-5744-8728
Kampmann, Martin https://orcid.org/0000-0002-3819-7019
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute on Aging (F30 AG066418, ZIA AG000957-16, R01 AG062359, R56 AG057528)
U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (DP2 GM132681, DP2 GM119139)
U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke (U54 NS100717)
Paul G. Allen Family Foundation (Allen Distinguished Investigator Award)
Article History
Received: 20 July 2020
Accepted: 23 April 2021
First Online: 24 May 2021
Competing interests
: M.K. has filed a patent application related to CRISPRi and CRISPRa screening () and serves on the Scientific Advisory Boards of Engine Biosciences, Casma Therapeutics and Cajal Neuroscience. The remaining authors declare no competing financial interests.